ENL的YEATS表观遗传阅读器结构域关键性地将MLL-ENL与t(11;19)白血病中的白血病干细胞频率相关联
研究探讨ENL的YEATS结构域在MLL-ENL介导的白血病发生中的作用。发现YEATS结构域在84.1%的MLL-ENL患者中保留,且对小鼠模型中MLL-ENL介导的白血病发生至关重要。删除YEATS结构域损害融合蛋白结合并降低促白血病基因表达;点突变降低干细胞频率并延长白血病潜伏期;含YEATS的MLL-ENL白血病细胞对YEATS抑制剂SGC-iMLLT更敏感。
要点
- YEATS结构域在84.1%的MLL-ENL患者中保留,对小鼠MLL-ENL白血病发生至关重要。
- YEATS缺失损害MLL-ENL结合并降低Eya1、Meis1等促白血病基因表达。
- 破坏YEATS与乙酰化组蛋白结合的点突变降低干细胞频率并延长白血病潜伏期。
核心结论
- YEATS结构域对MLL-ENL融合蛋白介导的白血病发生重要,并暴露可能用于治疗t(11;19)患者的治疗靶点。
研究设计与样本
- 研究使用小鼠模型和患者样本分析MLL-ENL中YEATS结构域的保留及其功能。
主要发现
- YEATS结构域在84.1%的MLL-ENL患者中保留。
- 删除YEATS结构域损害MLL-ENL融合蛋白结合并降低Eya1和Meis1表达。
- 破坏YEATS与乙酰化组蛋白结合的点突变降低干细胞频率并增加MLL-ENL介导的白血病潜伏期。
- 含YEATS的MLL-ENL白血病细胞对YEATS抑制剂SGC-iMLLT的敏感性高于对照AML细胞。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
MLL (KMT2a) translocations are found in ~10% of acute leukemia patients, giving rise to oncogenic MLL-fusion proteins. A common MLL translocation partner is ENL and associated with a poor prognosis in t(11;19) patients. ENL contains a highly conserved N-terminal YEATS domain that binds acetylated histones and interacts with the PAF1c, an epigenetic regulator protein complex essential for MLL-fusion leukemogenesis. Recently, wild-type ENL, and specifically the YEATS domain, was shown to be essential for leukemic cell growth. However, the inclusion and importance of the YEATS domain in MLL-ENL-mediated leukemogenesis remains unexplored. We found the YEATS domain is retained in 84.1% of MLL-ENL patients and crucial for MLL-ENL-mediated leukemogenesis in mouse models. Mechanistically, deletion of the YEATS domain impaired MLL-ENL fusion protein binding and decreased expression of pro-leukemic genes like Eya1 and Meis1. Point mutations that disrupt YEATS domain binding to acetylated histones decreased stem cell frequency and increased MLL-ENL-mediated leukemia latency. Therapeutically, YEATS containing MLL-ENL leukemic cells display increased sensitivity to the YEATS inhibitor SGC-iMLLT compared to control AML cells. Our results demonstrate that the YEATS domain is important for MLL-ENL fusion protein-mediated leukemogenesis and exposes an "Achilles heel" that may be therapeutically targeted for treating t(11;19) patients.
引用
- Hu H, Saha N, Yang Y, et al. The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia. Leukemia. 2022. PMID: 36435883. doi:10.1038/s41375-022-01765-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。